Your browser doesn't support javascript.
Classification of Lung diseases using Convolutional Neural Network algorithms
2nd IEEE Mysore Sub Section International Conference, MysuruCon 2022 ; 2022.
Article in English | Scopus | ID: covidwho-2192028
ABSTRACT
Since the publication of the book Covid-19, several investigations of varying kinds have been carried out all across the globe to see how well it predicted future events. The early lung illness known as pneumonia is intimately linked to the virus known as Covid-19, which causes severe inflammation of the chest (pneumonic condition). It is difficult for doctors and other medical professionals to differentiate Covid-19 from other lung diseases including pneumonia. As a consequence of this, we need an independent diagnostic platform that is able to provide clinical results in a timely and efficient manner. Chest X-ray screening is the method that provides the most reliable diagnosis of lung disease. The purpose of this investigation was to offer a condensed CNN (RMNet) model for COVID-19 classification. When compared to prior models, the solution that has been developed requires less memory and requires fewer processing resources. When it comes to COVID-19 classification, the performance of the recommended RMNet model ensemble that makes use of ResNet18, Inceptionv3, and MobileNetV2 is superior to that of previously cutting-edge methodologies. Additionally, the ensemble model makes less of a demand on available memory and is straightforward to incorporate into the backend of a smart device. Lung cancer is produced by the unrestrained growth of aberrant cells. This proliferation may begin in either of the lungs, but it most often originates in the cells that border the airways. Lung cancer can be prevented by maintaining a healthy immune system. These abnormal cells do not develop into lung tissue that is healthy;instead, they rapidly multiply and produce tumours. This is because of how they behave. The process by which cancer cells spread from the primary site of the disease to other parts of the body is referred to as "metastasis."Once the disease has spread to other areas of the body, it is much more challenging to treat it in an appropriate manner. Primary or secondary lung cancer is a classification that may be used to this disease. Primary lung cancer starts in the lungs, but secondary lung cancer starts elsewhere in the body, metastasizes, and then spreads to the lungs. Both types of lung cancer may be fatal. Because medical professionals consider them to be separate manifestations of the illness, they are not treated the same way because of this belief. The information offered by symptoms, in addition to the findings of a number of other tests, is taken into consideration by medical professionals when making a diagnosis of lung cancer. Imaging techniques such as chest X-rays, bronchoscopies, CT scans, MRI scans, and PET scans are examples of what are known as conventional imaging methods. In addition, the doctor will do a physical examination on the patient, as well as an inspection of the chest, and a test to determine whether or not there is blood in the sputum. The goal of each of these procedures is to zero in on the specific location of the tumour and determine whether other organs in the body may be at risk due to the presence of the malignant growth. © 2022 IEEE.
Keywords

Full text: Available Collection: Databases of international organizations Database: Scopus Language: English Journal: 2nd IEEE Mysore Sub Section International Conference, MysuruCon 2022 Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: Databases of international organizations Database: Scopus Language: English Journal: 2nd IEEE Mysore Sub Section International Conference, MysuruCon 2022 Year: 2022 Document Type: Article